{
    "clinical_study": {
        "@rank": "168042", 
        "arm_group": [
            {
                "arm_group_label": "Acetaminophen", 
                "arm_group_type": "Experimental", 
                "description": "Subjects will receive 1000mg of intravenous acetaminophen every 6 hours for 24 hours beginning with dural closure."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Other", 
                "description": "Subjects will receive 100cc of normal saline every 6 hours for 24 hours beginning at dural closure."
            }
        ], 
        "brief_summary": {
            "textblock": "This is a prospective randomized double blinded trial study involving 128 patients\n      undergoing any craniotomy procedure at Evanston Hospital. The patients will be randomized by\n      the sealed envelope technique. The anesthesiologist and nurses who will be administering the\n      placebo or intravenous acetaminophen will be blinded to the group in which patients are\n      assigned.\n\n      The following general perioperative data will be recorded: patient information/preoperative\n      data, procedural information, postoperative information, and overall satisfaction of pain\n      management at 24 hours after surgery.\n\n      Based on a pilot study (N-20) we expect that 25% of the placebo treated patients will\n      require no opioids in the first 24 hour postoperative period. With the use of intravenous\n      acetaminophen, it is hypothesized that the number of patients that do not require opioids in\n      the first 24 hours after surgery will double."
        }, 
        "brief_title": "The Efficacy of Intravenous Acetaminophen During The Perioperative Period Of Neurosurgical Patients Undergoing Craniotomies", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Craniotomy", 
            "Brain Surgery"
        ], 
        "detailed_description": {
            "textblock": "This is a prospective randomized double blinded trial study involving 128 patients\n      undergoing any craniotomy procedure at Evanston Hospital. The patients will be randomized by\n      the sealed envelope technique. The anesthesiologist and nurses who will be administering the\n      placebo or intravenous acetaminophen will be blinded to the group in which patients are\n      assigned.\n\n      The following information will be recorded for each patient enrolled in this study:\n\n        -  Patient information/Preoperative Data\n\n             -  Age, sex, height, weight, Body Surface Area (BSA)\n\n             -  Disease specific information\n\n             -  Primary diagnosis\n\n             -  Pertinent medical history\n\n             -  Medications\n\n             -  Pertinent changes in patient status\n\n        -  Procedural information\n\n             -  Operation type\n\n             -  Preoperative anesthetic medications\n\n             -  Induction meds, intra-operative anesthetic meds, and post-operative anesthetic\n                meds, pressors, anti-hypertensives\n\n             -  Duration of Surgery and Intubation\n\n             -  Amount of dilaudid equivalent narcotics\n\n        -  Postoperative Information\n\n             -  Amount of narcotics administered in the PACU\n\n             -  Amount of narcotics administered in the first 24 hour postoperative period\n\n             -  Amount of non-narcotic analgesics administered in the first 24 hour postoperative\n                period\n\n             -  Time to first rescue analgesic in the PACU\n\n             -  Amount of first rescue medication recorded\n\n             -  Assessment of Pain Intensity at T0.5 (30min into PACU stay) and T24 (24 hours\n                after end of surgery)  (A 10-cm VAS scale will be used and labeled no pain at its\n                left terminus and worst pain imaginable at its right terminus)\n\n             -  Temperature in degrees centigrade every 8 hours for 24hours.\n\n             -  CAM-ICU is performed by ICU nurses to detect delirium in patients every 8 hours\n                and will be documented on a data collection sheet for the first 24 hours\n\n             -  RASS is a sedation scoring system that is used in our ICU and is documented every\n                8 hours by ICU nursing. We will record the RASS score for the first 24 hours on a\n                data collection sheet as documented by the ICU nurse.\n\n             -  Overall satisfaction score at 24 hrs. \"Overall satisfaction with pain management\"\n                (scale 1 - 100)\n\n      Based on a pilot study (N-20) we expect that 25% of the placebo treated patients will\n      require no opioids in the first 24 hour postoperative period. With the use of intravenous\n      acetaminophen, it is hypothesized that the number of patients that do not require opioids in\n      the first 24 hours after surgery will double."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject are able to provide informed consent prior to participation in the study\n\n          -  Subjects must be scheduled to undergo elective open craniotomy procedure of > 2 hour\n             duration\n\n          -  Subjects must be >18 years old but less than 90 years old\n\n          -  Subjects must have an American Society of Anesthesiologists (ASA) class I-IV\n\n          -  Subjects must have the ability to communicate meaningfully with the investigator\n             staff and read/understand the study procedures and the use of pain scales\n\n        Exclusion Criteria:\n\n          -  Subjects used opioids or tramadol daily for >7 days before study medication\n             administration\n\n          -  Subjects had been treated with any of the following within 14 days of surgery:\n             chaparral, comfrey, germander, jin bu huan, kava, pennyroyal, skullcap, St. John's\n             wort, or valerian\n\n          -  Subjects who have a chronic pain condition, significant medical disease or laboratory\n             abnormality that in the investigator's judgment could compromise the subject's\n             welfare\n\n          -  Subjects with known hypersensitivity to opioids, acetaminophen or the inactive\n             ingredients\n\n          -  Subjects with known or suspected history of alcohol or drug abuse or dependence in\n             the previous 2 years prior to the proposed surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "90 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "128", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 28, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01739699", 
            "org_study_id": "EH11-380"
        }, 
        "intervention": [
            {
                "arm_group_label": "Acetaminophen", 
                "intervention_name": "Acetaminophen", 
                "intervention_type": "Drug", 
                "other_name": "Tylenol"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "normal saline"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetaminophen"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "craniotomy", 
            "brain surgery", 
            "acetaminophen", 
            "Tylenol"
        ], 
        "lastchanged_date": "November 29, 2012", 
        "location": {
            "contact": {
                "last_name": "Steven Greenberg, MD"
            }, 
            "facility": {
                "address": {
                    "city": "Evanston", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60201"
                }, 
                "name": "NorthShore University HealthSystem"
            }, 
            "investigator": {
                "last_name": "Steven Greenberg, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Efficacy of Intravenous Acetaminophen During The Perioperative Period Of Neurosurgical Patients Undergoing Craniotomies", 
        "overall_contact": {
            "email": "sbgreenb@gmail.com", 
            "last_name": "Steven Greenberg, MD", 
            "phone": "847-570-2760"
        }, 
        "overall_contact_backup": {
            "email": "spatel6@northshore.org", 
            "last_name": "Shivani Patel", 
            "phone": "847-570-2760"
        }, 
        "overall_official": {
            "affiliation": "NorthShore University Health Sytem - Evanston Hospital Department of Anesthesia", 
            "last_name": "Steven Greenberg, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Amount of opioid requirement in addition to the study intervention(placebo or acetaminophen) will be recorded for the first 24 hours after surgery.", 
            "measure": "Opioid requirement after surgery", 
            "safety_issue": "No", 
            "time_frame": "during first 24 hours after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01739699"
        }, 
        "responsible_party": {
            "investigator_affiliation": "NorthShore University HealthSystem Research Institute", 
            "investigator_full_name": "Dr. Steven Greenberg", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Time to rescue medication in both groups", 
                "safety_issue": "No", 
                "time_frame": "0 to 24 hours after surgery"
            }, 
            {
                "measure": "Amount of rescue medication in PACU in both groups", 
                "safety_issue": "No", 
                "time_frame": "0 to 24 hours after surgery"
            }, 
            {
                "measure": "Median difference in ICU length of stay/hospital length of stay between both groups", 
                "safety_issue": "No", 
                "time_frame": "from 0 to estimated maximum of 7 days after surgery"
            }, 
            {
                "measure": "Number of successful neurologic exams between intervention and placebo group as determined by a neurosurgical provider by answering either Yes or No", 
                "safety_issue": "No", 
                "time_frame": "from 0 to estimated maximum of 7 days after surgery"
            }, 
            {
                "measure": "Median difference in temperature between intervention and placebo groups", 
                "safety_issue": "No", 
                "time_frame": "from 0 to estimated maximum of 7 days after surgery"
            }, 
            {
                "measure": "Sedation scores measured by RASS every 8 hours for 24 hours in both groups", 
                "safety_issue": "No", 
                "time_frame": "during first 24 hours after surgery"
            }, 
            {
                "measure": "Pain VAS scores (1-10) every 8 hours for 24 hours in both groups", 
                "safety_issue": "No", 
                "time_frame": "during first 24 hours after surgery"
            }, 
            {
                "measure": "Delirium measured by CAM-ICU every 8 hours for 24 hours in both groups", 
                "safety_issue": "No", 
                "time_frame": "during first 24 hours after surgery"
            }
        ], 
        "source": "NorthShore University HealthSystem Research Institute", 
        "sponsors": {
            "collaborator": {
                "agency": "Cadence Pharmaceuticals", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "NorthShore University HealthSystem Research Institute", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2012"
    }
}